Harvard study – Exclusive market rights encouraging high drug prices
In a remarkable Harvard Study, the key reasons behind the high drug prices in the United States (US) have been […]
Tags: Aaron Kesselheim, Ameet Sarpatwari, Engelberg Foundation, Food and Drugs Administration, Generic drug, Harvard, Harvard Study, JAMA, Jerry Avorn, John Arnold Foundation, medicaid, Monopoly, Pharma Companies, Prescription drug, research and development, the Journal of the American Medical Association, United States
